Numerous strategies have been developed to treat cancer conventionally. Most importantly,
chemotherapy shows its huge promise as a better treatment modality over others …

Due to the lack of cure for inflammatory bowel disease (IBD) and failure of current medical
therapies in many patients with IBD, a need exists in finding novel ways to treat inflammation …

Drug development is an expensive and time-consuming process; these could be reduced if
the existing resources could be used to identify candidates for drug repurposing. This study …

Prostate cancer (PCa) is the most common male urogenital malignancy worldwide. Surgery,
endocrine therapy, radiotherapy, and chemotherapy are the main clinical management …

Castrate-resistant prostate cancer (CRPC) remains incurable due to the lack of effective
therapies. Several tyrosine kinases have been implicated in the development and growth of …

Recent advances in cancer nanomedicine have attracted remarkable attention in medical
sectors. Pharmacologic research on nanomedicines, including targeted cancer therapy, has …

Triple-negative breast cancer (TNBC) is an aggressive subtype of breast cancer that differs
in progression, recurrence, and prognosis from other forms of breast cancer. The …

Oral administration of paclitaxel (PTX), a broad spectrum anticancer agent, is challenged by
its low uptake due to its poor bioavailability, efflux through P-glycoprotein, and …

Background: Castrate-resistant prostate cancer (CRPC) patients are characterised by a 5-
year relative survival rate of∼ 25–33%. Recently, our laboratory encapsulated a selective …

Synthetic cannabinoid WIN55, 212-2 (WIN) has shown a promise as an anticancer agent but
causes psychoactive side-effects. In the present study, nano-micelles of styrene maleic acid …